Monday Dec 2
Affymetrix Receives Outperform Rating from Zacks
's stock had its "outperform" rating reaffirmed by Zacks in a research note issued to investors on Monday, AR Network reports.
SADIF Analytics releases new summary due diligence report for Affymetrix, Inc.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Affymetrix, Inc. .
Affymetrix Given New $12.00 Price Target at Mizuho
The firm currently has a "buy" rating on the stock. Mizuho's target price suggests a potential upside of 52.57% from the stock's previous close.
Research Alert-Affymetrix: Mizuho raises target price
Affymetrix Inc : * Mizuho raises target price to $12 from $10; rating buy For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on ... (more)
Affymetrix Director Robert Trice Unloads 6,205 Shares
Affymetrix Director Robert Trice sold 6,205 shares of the stock in a transaction dated Tuesday, November 19th.
Trader's Round Up: Affymetrix, Inc. (NASDAQ:AFFX), Global Eagle...
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
New Microarray for Identifying and Subtyping Pathogenic E. coli Using Unique DNA Signatures
These high density DNA-based microarray assays, for use with the GeneAtlasA Personal Microarray System , can detect, discriminate, and uniquely identify strains of E. coli on food products, clinical samples, and environmental samples in real-time outbreak situations.